ALBEMARLE ($ALB) posted quarterly earnings results on Wednesday, November 5th. The company reported earnings of -$0.19 per share, beating estimates of -$0.79 by $0.60. The company also reported revenue of $1,307,830,000, beating estimates of $1,289,266,070 by $18,563,930.
You can see Quiver Quantitative's $ALB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALBEMARLE Insider Trading Activity
ALBEMARLE insiders have traded $ALB stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ALB stock by insiders over the last 6 months:
- ANDER C. KRUPA (General Counsel & Sec) has made 0 purchases and 2 sales selling 288 shares for an estimated $29,080.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALBEMARLE Hedge Fund Activity
We have seen 354 institutional investors add shares of ALBEMARLE stock to their portfolio, and 401 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 1,726,141 shares (-17.3%) from their portfolio in Q2 2025, for an estimated $108,177,256
- MANNING & NAPIER ADVISORS LLC added 1,596,717 shares (+inf%) to their portfolio in Q3 2025, for an estimated $129,461,814
- SQUAREPOINT OPS LLC added 955,227 shares (+123.3%) to their portfolio in Q2 2025, for an estimated $59,864,076
- PROSHARE ADVISORS LLC added 937,538 shares (+48.5%) to their portfolio in Q2 2025, for an estimated $58,755,506
- FRANKLIN RESOURCES INC added 910,806 shares (+18.7%) to their portfolio in Q2 2025, for an estimated $57,080,212
- AQR CAPITAL MANAGEMENT LLC added 710,589 shares (+22047.4%) to their portfolio in Q2 2025, for an estimated $44,532,612
- THRIVENT FINANCIAL FOR LUTHERANS added 636,561 shares (+3072.2%) to their portfolio in Q3 2025, for an estimated $51,612,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALBEMARLE Congressional Stock Trading
Members of Congress have traded $ALB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ALB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ALBEMARLE Analyst Ratings
Wall Street analysts have issued reports on $ALB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Rothschild & Co issued a "Buy" rating on 10/24/2025
- Baird issued a "Underperform" rating on 08/29/2025
To track analyst ratings and price targets for ALBEMARLE, check out Quiver Quantitative's $ALB forecast page.
ALBEMARLE Price Targets
Multiple analysts have issued price targets for $ALB recently. We have seen 10 analysts offer price targets for $ALB in the last 6 months, with a median target of $87.0.
Here are some recent targets:
- Mazahir Mammadli from Rothschild & Co set a target price of $135.0 on 10/24/2025
- Peter Osterland from Truist Securities set a target price of $87.0 on 10/20/2025
- Michael Sison from Wells Fargo set a target price of $90.0 on 10/15/2025
- Matthew DeYoe from B of A Securities set a target price of $100.0 on 10/14/2025
- Joshua Spector from UBS set a target price of $85.0 on 10/06/2025
- John Roberts from Mizuho set a target price of $92.0 on 10/03/2025
- Ben Kallo from Baird set a target price of $68.0 on 08/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
